CVS Health Corporation
CVS
$65.51
$0.630.97%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 6.21% | 4.75% | 3.93% | 5.96% | 7.03% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 6.21% | 4.75% | 3.93% | 5.96% | 7.03% |
Cost of Revenue | 7.53% | 5.99% | 5.95% | 7.89% | 8.73% |
Gross Profit | -1.67% | -2.54% | -7.56% | -4.69% | -2.06% |
SG&A Expenses | 3.41% | 4.51% | 4.94% | 5.74% | 4.30% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 7.06% | 5.82% | 5.84% | 7.64% | 8.20% |
Operating Income | -19.22% | -24.87% | -42.35% | -32.83% | -19.09% |
Income Before Tax | -32.63% | -27.23% | -44.97% | -42.10% | 132.03% |
Income Tax Expenses | -17.69% | -23.10% | -44.31% | -42.09% | 109.01% |
Earnings from Continuing Operations | -37.69% | -28.65% | -45.20% | -42.10% | 141.02% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 400.00% | 224.14% | 216.67% | 128.57% | 41.67% |
Net Income | -36.98% | -27.88% | -44.70% | -41.89% | 142.50% |
EBIT | -19.22% | -24.87% | -42.35% | -32.83% | -19.09% |
EBITDA | -13.32% | -17.66% | -31.08% | -23.65% | -12.91% |
EPS Basic | -36.28% | -26.54% | -43.51% | -40.91% | 141.13% |
Normalized Basic EPS | -13.37% | -19.61% | -40.08% | -33.72% | -20.57% |
EPS Diluted | -36.30% | -26.40% | -43.35% | -40.69% | 143.19% |
Normalized Diluted EPS | -13.26% | -19.47% | -39.99% | -33.62% | -20.51% |
Average Basic Shares Outstanding | -0.90% | -1.62% | -2.08% | -1.94% | -1.93% |
Average Diluted Shares Outstanding | -1.08% | -1.83% | -2.23% | -2.10% | -1.98% |
Dividend Per Share | 4.72% | 7.26% | 9.92% | 9.94% | 9.96% |
Payout Ratio | 0.65% | 0.46% | 0.95% | 0.86% | -0.56% |